Publications in collaboration with researchers from Centro de Investigación Biomédica en Red sobre Enfermedades Raras (1)

2023

  1. NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy

    Cell Reports Medicine, Vol. 4, Núm. 12